Kenneth Omollo1,2, Julie Lajoie1,3, Julius Oyugi1,3, Jocelyn M Wessels4, Dufton Mwaengo1, Joshua Kimani1,2, Charu Kaushic4,5, Keith R Fowke1,2,3,6. 1. Department Medical Microbiology, University of Nairobi, Nairobi, Kenya. 2. Partners for Health and Development in Africa, Nairobi, Kenya. 3. Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada. 4. McMaster Immunology Research Centre, Michael G. DeGroote Centre for Learning and Discovery, McMaster University, Hamilton, ON, Canada. 5. Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. 6. Department of Community Health Science, University of Manitoba, Winnipeg, MB, Canada.
Abstract
Background: Depot Medroxyprogesterone (DMPA) is one of the most widely used contraceptives in Sub-Saharan Africa where HIV incidence is high. We explored the effect of DMPA on the activation of HIV cellular targets and inflammation as a possible mechanism of increased HIV risk with DMPA use. Since sex work is known to affect the immune system, this study aimed to understand the effect of DMPA on the immune system among sex workers and non-sex worker women. Methods: Twenty-seven DMPA-using HIV seronegative female sex workers (FSW) and 30 DMPA-using HIV seronegative non-sex worker (SW) women were enrolled in the study. Twenty-four FSWs and 30 non-sex workers who were not using any hormonal contraception (no HC) were recruited as controls. Blood and cervico-vaginal samples were collected from all participants and assayed for T cell activation and proinflammatory cytokines. Results: Among no HC users, sex workers had lower expression of CD38 and CD69 on blood-derived CD4+ T cells along with lower CD4+CCR5+ cells frequency in the endocervix. Plasma MCP-1, TNFα and IL-17 also had reduced expression in FSW not using HC. Non-sex workers using DMPA had elevated proportions of blood-derived CD4+CD38+, CD4+CD69+ and CD4+HLA-DR+ T cells relative to non-sex workers who were not taking any HC. DMPA-using non-sex workers also had an increased level of plasma interferon gamma (IFN-γ), monokine induced by interferon-γ (MIG) and sCD40L, alongside higher proportion of CD4+CD38+ and CD4+CD69+ T cells at the cervix compared to non-sex workers no-HC controls., Finally, non-sex workers and FSWs using DMPA had similar levels of genital and peripheral CD4+ T cell activation and inflammation. Conclusion: DMPA increased inflammation and expression of activation markers on potential HIV target cells in non-sex workers. These data show that DMPA is a strong immune modulator and its use counteracts the decreased immune activation associated with sex work. These findings suggest that inflammation and increased HIV target cells in blood and at the genital tract may be mechanisms by which DMPA increases susceptibility to HIV.
Background: Depot Medroxyprogesterone (DMPA) is one of the most widely used contraceptives in Sub-Saharan Africa where HIV incidence is high. We explored the effect of DMPA on the activation of HIV cellular targets and inflammation as a possible mechanism of increased HIV risk with DMPA use. Since sex work is known to affect the immune system, this study aimed to understand the effect of DMPA on the immune system among sex workers and non-sex worker women. Methods: Twenty-seven DMPA-using HIV seronegative female sex workers (FSW) and 30 DMPA-using HIV seronegative non-sex worker (SW) women were enrolled in the study. Twenty-four FSWs and 30 non-sex workers who were not using any hormonal contraception (no HC) were recruited as controls. Blood and cervico-vaginal samples were collected from all participants and assayed for T cell activation and proinflammatory cytokines. Results: Among no HC users, sex workers had lower expression of CD38 and CD69 on blood-derived CD4+ T cells along with lower CD4+CCR5+ cells frequency in the endocervix. Plasma MCP-1, TNFα and IL-17 also had reduced expression in FSW not using HC. Non-sex workers using DMPA had elevated proportions of blood-derived CD4+CD38+, CD4+CD69+ and CD4+HLA-DR+ T cells relative to non-sex workers who were not taking any HC. DMPA-using non-sex workers also had an increased level of plasma interferon gamma (IFN-γ), monokine induced by interferon-γ (MIG) and sCD40L, alongside higher proportion of CD4+CD38+ and CD4+CD69+ T cells at the cervix compared to non-sex workers no-HC controls., Finally, non-sex workers and FSWs using DMPA had similar levels of genital and peripheral CD4+ T cell activation and inflammation. Conclusion:DMPA increased inflammation and expression of activation markers on potential HIV target cells in non-sex workers. These data show that DMPA is a strong immune modulator and its use counteracts the decreased immune activation associated with sex work. These findings suggest that inflammation and increased HIV target cells in blood and at the genital tract may be mechanisms by which DMPA increases susceptibility to HIV.
Authors: J Lajoie; J Juno; A Burgener; S Rahman; K Mogk; C Wachihi; J Mwanjewe; F A Plummer; J Kimani; T B Ball; K R Fowke Journal: Mucosal Immunol Date: 2012-02-08 Impact factor: 7.313
Authors: Elizabeth H Byrne; Melis N Anahtar; Kathleen E Cohen; Amber Moodley; Nikita Padavattan; Nasreen Ismail; Brittany A Bowman; Gregory S Olson; Amanda Mabhula; Alasdair Leslie; Thumbi Ndung'u; Bruce D Walker; Musie S Ghebremichael; Krista L Dong; Douglas S Kwon Journal: Lancet Infect Dis Date: 2015-12-24 Impact factor: 25.071
Authors: Grant R Yeaman; Alexandra L Howell; Sally Weldon; Douglas J Demian; Jane E Collins; Denise M O'Connell; Susana N Asin; Charles R Wira; Michael W Fanger Journal: Immunology Date: 2003-05 Impact factor: 7.397
Authors: H L Martin; P M Nyange; B A Richardson; L Lavreys; K Mandaliya; D J Jackson; J O Ndinya-Achola; J Kreiss Journal: J Infect Dis Date: 1998-10 Impact factor: 5.226
Authors: Charles S Morrison; Raina Fichorova; Pai-Lien Chen; Cynthia Kwok; Jennifer Deese; Hidemi Yamamoto; Sharon Anderson; Tsungai Chipato; Robert Salata; Gustavo F Doncel Journal: AIDS Res Hum Retroviruses Date: 2018-09-05 Impact factor: 2.205
Authors: Francisco Dominguez; Arancha Galan; Jose Juan Luna Martin; Jose Remohi; Antonio Pellicer; Carlos Simón Journal: Mol Hum Reprod Date: 2003-04 Impact factor: 4.025
Authors: Catherine M Card; Paul J McLaren; Charles Wachihi; Joshua Kimani; Francis A Plummer; Keith R Fowke Journal: J Infect Dis Date: 2009-05-01 Impact factor: 5.226
Authors: Rupert Kaul; Cindy M Liu; Daniel E Park; Ronald M Galiwango; Aaron A R Tobian; Jessica L Prodger Journal: Viruses Date: 2022-05-27 Impact factor: 5.818
Authors: Smritee Dabee; Ramla F Tanko; Bryan P Brown; Rubina Bunjun; Christina Balle; Colin Feng; Iyaloo N Konstantinus; Shameem Z Jaumdally; Maricianah Onono; Gonasagrie Nair; Thesla Palanee-Phillips; Katherine Gill; Jared M Baeten; Linda-Gail Bekker; Jo-Ann S Passmore; Renee Heffron; Heather B Jaspan; Anna-Ursula Happel Journal: Front Immunol Date: 2021-12-09 Impact factor: 7.561